🇺🇸 FDA
Patent

US 10925874

Substituted pyrazolopyrimidines as glucocerebrosidase activators

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 10925874 (Substituted pyrazolopyrimidines as glucocerebrosidase activators) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/519, A61K31/5377, A61P, A61P43/00